# Syrna Therapeutics, Inc. — Form D

Syrna Therapeutics, Inc. of DEL MAR, CA, a company, filed a Form D exempt-offering notice with the SEC on 2023-08-10. The offering totals $10.9M, of which $10.9M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2023-08-10
- Form: D
- Accession: 0001989653-23-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $10.9M
- Amount sold: $10.9M
- Investors: 3
- Date of first sale: 2023-08-02
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-489346

## Issuer

- Name: Syrna Therapeutics, Inc.
- CIK: 0001989653
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 13759 PINE NEEDLES DRIVE, DEL MAR, CA, 92014
- Phone: 858-735-1184

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Aiden Aceves | Director | Cary, NC |
| Joel Dudley | Director | New Haven, CT |
| Thomas Hermann | Director | Del Mar, CA |
| David Weitz | Director | Del Mar, CA |
| David Weitz | Executive Officer | Del Mar, CA |

## More

- [CIK 1989653 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1989653&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001989653-23-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.